BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbe MF, Hilliard BA, Amin M, Harris MY, Hobson LJ, Cruz GE, Popoff SN. Blocking CTGF/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury. FASEB J 2020;34:6554-69. [PMID: 32227398 DOI: 10.1096/fj.202000240RR] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Hilliard BA, Amin M, Popoff SN, Barbe MF. Force dependent effects of chronic overuse on fibrosis-related genes and proteins in skeletal muscles. Connect Tissue Res 2021;62:133-49. [PMID: 33030055 DOI: 10.1080/03008207.2020.1828379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Klyne DM, Barbe MF, James G, Hodges PW. Does the Interaction between Local and Systemic Inflammation Provide a Link from Psychology and Lifestyle to Tissue Health in Musculoskeletal Conditions? Int J Mol Sci 2021;22:7299. [PMID: 34298917 DOI: 10.3390/ijms22147299] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Barbe MF, Hilliard BA, Amin M, Harris MY, Hobson LJ, Cruz GE, Popoff SN. Blocking CTGF/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury. FASEB J 2020;34:6554-69. [PMID: 32227398 DOI: 10.1096/fj.202000240RR] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
4 Barbe MF, Hilliard BA, Amin M, Harris MY, Hobson LJ, Cruz GE, Dorotan JT, Paul RW, Klyne DM, Popoff SN. Blocking CTGF/CCN2 reverses neural fibrosis and sensorimotor declines in a rat model of overuse-induced median mononeuropathy. J Orthop Res 2020;38:2396-408. [PMID: 32379362 DOI: 10.1002/jor.24709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Rebolledo DL, Acuña MJ, Brandan E. Role of Matricellular CCN Proteins in Skeletal Muscle: Focus on CCN2/CTGF and Its Regulation by Vasoactive Peptides. Int J Mol Sci 2021;22:5234. [PMID: 34063397 DOI: 10.3390/ijms22105234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Petrosino JM, Longenecker JZ, Angel CD, Hinger SA, Martens CR, Accornero F. CCN2 participates in overload-induced skeletal muscle hypertrophy. Matrix Biol 2022:S0945-053X(22)00003-8. [PMID: 35045313 DOI: 10.1016/j.matbio.2022.01.003] [Reference Citation Analysis]
7 Barbe MF, Harris MY, Cruz GE, Amin M, Billett NM, Dorotan JT, Day EP, Kim SY, Bove GM. Key indicators of repetitive overuse-induced neuromuscular inflammation and fibrosis are prevented by manual therapy in a rat model. BMC Musculoskelet Disord 2021;22:417. [PMID: 33952219 DOI: 10.1186/s12891-021-04270-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fu M, Peng D, Lan T, Wei Y, Wei X. Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.007] [Reference Citation Analysis]
9 Leguit RJ, Raymakers RAP, Hebeda KM, Goldschmeding R. CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis. J Cell Commun Signal 2021;15:25-56. [PMID: 33428075 DOI: 10.1007/s12079-020-00602-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Barbe MF, Amin M, Gingery A, Lambi AG, Popoff SN. Blocking CCN2 preferentially inhibits osteoclastogenesis induced by repetitive high force bone loading. Connect Tissue Res 2021;62:115-32. [PMID: 32683988 DOI: 10.1080/03008207.2020.1788546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Bittel AJ, Sreetama SC, Bittel DC, Horn A, Novak JS, Yokota T, Zhang A, Maruyama R, Rowel Q Lim K, Jaiswal JK, Chen YW. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy. Int J Mol Sci 2020;21:E5575. [PMID: 32759720 DOI: 10.3390/ijms21155575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
12 Barbe MF, Panibatla ST, Harris MY, Amin M, Dorotan JT, Cruz GE, Bove GM. Manual Therapy With Rest as a Treatment for Established Inflammation and Fibrosis in a Rat Model of Repetitive Strain Injury. Front Physiol 2021;12:755923. [PMID: 34803739 DOI: 10.3389/fphys.2021.755923] [Reference Citation Analysis]
13 Rebolledo DL, Lipson KE, Brandan E. Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2/CTGF). Matrix Biol Plus 2021;11:100059. [PMID: 34435178 DOI: 10.1016/j.mbplus.2021.100059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tam AYY, Horwell AL, Trinder SL, Khan K, Xu S, Ong V, Denton CP, Norman JT, Holmes AM, Bou-Gharios G, Abraham DJ. Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension. Int J Biochem Cell Biol 2021;134:105961. [PMID: 33662577 DOI: 10.1016/j.biocel.2021.105961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Peng L, Wei Y, Shao Y, Li Y, Liu N, Duan L. The Emerging Roles of CCN3 Protein in Immune-Related Diseases. Mediators Inflamm 2021;2021:5576059. [PMID: 34393649 DOI: 10.1155/2021/5576059] [Reference Citation Analysis]
16 Leask A. Slow train coming: an anti-CCN2 strategy reverses a model of chronic overuse muscle fibrosis. J Cell Commun Signal 2020;14:349-50. [PMID: 32410169 DOI: 10.1007/s12079-020-00568-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]